Effects of molsidomine on scopolamine-induced
amnesia and hypermotility in the rat

Pitsikas N, Rigamonti AE, Cella SG, Locatelli V, Sala M, Muller EE.
Department of Medical Pharmacology,
Faculty of Medicine, University of Milan,
via Vanvitelli 32, 20129 Milan, Italy.
Eur J Pharmacol2001 Aug 31;426(3):193-2008


Nitric oxide (NO) is hypothesized to be a novel intracellular messenger in the central nervous system. Recently, NO involvement in learning and memory processes has been proposed. Compounds that inhibit nitric oxide synthase, the key synthesizing enzyme, may block cognition, while NO donors may facilitate it. The aim of this study was to assess in the rat the effects of the NO donor molsidomine (2 and 4 mg/kg, i.p.) on memory deficits caused by scopolamine. For this purpose, the object recognition task and the step-through passive avoidance procedure were chosen. In addition, the effects of molsidomine in antagonizing the scopolamine-induced hypermotility were also examined. Scopolamine at 0.2 mg/kg (object recognition) and 0.75 mg/kg (passive avoidance) disrupted acquisition in both the tasks and induced locomotor hyperactivity at the dose of 0.2 mg/kg. Molsidomine at either dose reversed the scopolamine-induced deficits in the object recognition paradigm but did not counteract the hypermotility and the deficits occurred in the passive avoidance test. These results suggest that to some extent, the NO donor molsidomine is involved in memory processing.

Nitric oxide
New brain cells
The memory switch?
Dumb-drug euphoria
Growing new brain cells
CRF, vasopressin and memory
Vasopressin, memory and the hippocampus
Vasopressin and memory in healthy humans

and further reading

Future Opioids
BLTC Research
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family